BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 13, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: After iffy adcom, FDA clears Urogen’s Zusduri mitomycin
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Home
»
Topics
» BioWorld Science, Neurology/psychiatric
BioWorld Science, Neurology/psychiatric
RSS
IRI-695 for anxiety and depression
April 26, 1996
TAD-93 in preclinical studies for anxiety
April 26, 1996
New 5-HT1D antagonists from Pierre Fabre
April 26, 1996
SKB reports 5-HT2B/2C antagonists for CNS indications
April 26, 1996
Adolor aims to advance ADL-2-1294 into clinical trials
April 26, 1996
BMS antimigraine agent poised to enter clinical trials
April 26, 1996
NPC-18688 displays long-lasting antihyperalgesic effects in rodents
April 26, 1996
SKB claims morphinoid derivatives
April 26, 1996
OT-7100, Otsuka's new analgesic for peripheral pain
April 26, 1996
Combined thrombolytic/neuroprotective agents more effective in treating stroke
April 19, 1996
Previous
1
2
…
2738
2739
2740
2741
2742
2743
2744
2745
2746
2747
2748
2749
Next
RSS